Current & Future Directions in Chronic and Acute Leukemias

 Friday, September 13, 2019
Time: Registration and Breakfast at 6:00 AM | Educational Symposium from 6:15 AM - 7:45 AM
Hilton Americas | Grand Ballroom G-L, Level 4

Symposium Overview
This symposium will be presented by 3 world-renowned experts actively engaged in the care of patients with chronic and acute leukemias. 

Target Audience
The target audience for this symposium is community and academic hematologists, oncologists, and all healthcare professionals involved in the care and treatment of patients with CML and acute leukemias.

Learning Objectives
After completing this symposium, participants should be better able to:

  • Evaluate clinical data of various TKI-based therapies for patients with CML, including newly diagnosed patients and those in later lines of therapy
  • Assess various treatment strategies for patients with relapsed/refractory ALL, in consideration of salvage status, MRD, and cytogenetics
  • Compare and contrast therapeutic approaches for newly diagnosed patients with AML, including patients that are both eligible and ineligible for intensive induction chemotherapy

Continuing Education
The University of Nebraska Medical Center, Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The University of Nebraska Medical Center, Center for Continuing Education, designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the University of Nebraska Medical Center, Center for Continuing Education and Bio Ascend.

6:00 AM    Registration and Breakfast                                                                                                                                                                         

6:15 AM    Welcome, Introductions, and Presession Survey

6:20 AM    CML: Moving Next Generation TKIs Into Earlier Lines of Therapy
                 Elias Jabbour, MD - Chair                                                                                   

6:45 AM   ALL: How Best to Manage Patients in the Relapsed/Refractory Setting
                Susan O’Brien, MD                                                                                 

7:10 AM    AML: Selecting Therapy for Newly Diagnosed Patients
                 Hagop Kantarjian, MD                                                                                              

7:35 AM   Audience Q&A                                               

7:40 AM   Summary

7:45 AM   Program Adjourn 

Elias Jabbour, MD - Chair
Professor, Department of Leukemia
Division of Cancer Medicine
The University of Texas
MD Anderson Cancer Center

Houston, Texas

Hagop Kantarjian, MD
Professor and Chair, Department and Leukemia
The University of Texas
MD Anderson Cancer Center
Houston, Texas

Susan O’Brien, MD
Associate Director for Clinical Services, Chao Family Comprehensive Cancer Center
University of California
Irvine Medical Center
Irvine, California

Faculty Disclosure Statement
All presenters, planners, and others in a position to control continuing medical education content participating in a University of Nebraska Medical Center, Center for Continuing Education activity are required to disclose relationships with commercial interests. A commercial interest is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. Disclosure of these commitments and/or relationships is included in activity materials so that participants in the activity may formulate their own judgments in interpreting its content and evaluating its recommendations.

Space is limited and pre-registration is recommended to reserve your seat. If your plans change and you are no longer able to attend, please cancel your registration to allow others to register. There is no fee to register for this activity. 

American Disabilities Act (ADA)
In compliance with the Americans with Disabilities Act, the UNMC Center for Continuing Education does not discriminate on the basis of disability. The University of Nebraska Medical Center, Center for Continuing Education and Bio Ascend shall provide reasonable accommodations, including auxiliary aids and services, to ensure equal access to its activities and services. If you would like an auxiliary aid or service, please call 888-476-9129 or e-mail  by 9/6/2019 with your request.

This activity is supported by an independent educational grant from Pfizer Inc.

Not an official event of the SOHO 2019 Annual Meeting. Not sponsored or endorsed by the Society of Hematologic Oncology.

Select the Continue button below to register.